MiMedx Group Inc (MDXG)
7.37
-0.13
(-1.73%)
USD |
NASDAQ |
May 03, 16:00
7.365
0.00 (0.00%)
After-Hours: 20:00
MiMedx Group 1 Year Total Returns (Daily): 38.79% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 03, 2024 | 38.79% |
May 02, 2024 | 96.85% |
May 01, 2024 | 89.87% |
April 30, 2024 | 60.84% |
April 29, 2024 | 63.45% |
April 26, 2024 | 76.62% |
April 25, 2024 | 70.63% |
April 24, 2024 | 70.56% |
April 23, 2024 | 73.60% |
April 22, 2024 | 69.60% |
April 19, 2024 | 84.46% |
April 18, 2024 | 83.33% |
April 17, 2024 | 86.73% |
April 16, 2024 | 88.22% |
April 15, 2024 | 91.84% |
April 12, 2024 | 105.1% |
April 11, 2024 | 100.3% |
April 10, 2024 | 98.48% |
April 09, 2024 | 111.4% |
April 08, 2024 | 107.8% |
April 05, 2024 | 114.1% |
April 04, 2024 | 118.7% |
April 03, 2024 | 109.9% |
April 02, 2024 | 101.8% |
April 01, 2024 | 118.5% |
Date | Value |
---|---|
March 28, 2024 | 131.2% |
March 27, 2024 | 123.2% |
March 26, 2024 | 124.8% |
March 25, 2024 | 131.0% |
March 22, 2024 | 133.7% |
March 21, 2024 | 128.6% |
March 20, 2024 | 133.0% |
March 19, 2024 | 118.2% |
March 18, 2024 | 113.6% |
March 15, 2024 | 121.3% |
March 14, 2024 | 108.0% |
March 13, 2024 | 105.4% |
March 12, 2024 | 107.5% |
March 11, 2024 | 107.8% |
March 08, 2024 | 102.0% |
March 07, 2024 | 94.05% |
March 06, 2024 | 89.44% |
March 05, 2024 | 81.00% |
March 04, 2024 | 86.88% |
March 01, 2024 | 106.2% |
February 29, 2024 | 69.65% |
February 28, 2024 | 70.48% |
February 27, 2024 | 77.97% |
February 26, 2024 | 83.56% |
February 23, 2024 | 81.82% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-78.70%
Minimum
Sep 07 2022
534.8%
Maximum
Dec 09 2019
40.81%
Average
22.19%
Median
Nov 16 2021
1 Year Total Returns (Daily) Benchmarks
TELA Bio Inc | -50.32% |
Amylyx Pharmaceuticals Inc | -92.77% |
CEL-SCI Corp | -27.23% |
AIM ImmunoTech Inc | -15.65% |
IGC Pharma Inc | 53.98% |